{"entity":{"id":"da-trial-e2814","kind":"trial","name":"E2814 tau antibody (DIAD)","aka":[],"tldr":"A Phase 2 study of E2814, an investigational anti-tau antibody, in people with genetic early Alzheimer’s disease.","summary":"Target-engagement and safety study in a DIAD population. Not an approved treatment and not a DIY protocol.","status":"recruiting","asOf":"2026-09-21","links":[{"label":"ClinicalTrials.gov NCT04971733","url":"https://clinicaltrials.gov/study/NCT04971733"}],"tags":["dementia-atlas"],"related":[],"cancers":["alzheimers-disease"],"sections":[],"technologies":[],"targets":[],"drugs":["da-e2814"],"companies":["da-eisai"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT04971733","phase":"2","setting":"Dominantly inherited Alzheimer’s disease","sponsor":"Eisai","outcomes":[]},"route":"/trials/da-trial-e2814/","neighbours":{"cancer":[{"id":"alzheimers-disease","kind":"cancer","name":"Alzheimer’s disease","route":"/diagnoses/alzheimers-disease/"}],"drug":[{"id":"da-e2814","kind":"drug","name":"E2814","route":"/drugs/da-e2814/"}],"company":[{"id":"da-eisai","kind":"company","name":"Eisai","route":"/companies/da-eisai/"}]}}